Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News

23:59 EDT 27th May 2016 | BioPortfolio

Showing News Articles 1–25 of 520,000+

Friday 27th May 2016

Sinovac: China Vaccine Sales Drop Due to New Government Policies

Sinovac Biotech, a Beijing vaccine company, reported that new government regulations caused China vaccine revenues to fall 50% in Q1. After the recent vaccine distribution scandal in Shandong Province, China's State Council required vaccine makers to participate in the provincial tendering process -- even though their products are sold to the private pay market. Provincial drug councils don't have...

Rigaku to Present Latest X-ray Diffraction Instruments at PPXRD-14

Rigaku is featuring its latest XRD systems at the 14th Pharmaceutical Powder X-ray Diffraction Symposium Fort Meyers, FL (PRWEB) May 27, 2016 Rigaku Corporation is pleased to announce its attendance at the 14th Pharmaceutical Powder X-ray Diffraction Symposium (PPXRD-14). Rigaku is presenting its current line of analytical X-ray diffraction instrumentation June 7-8, 2016 in Fort Myers, Florida at...

Recent Bariatric Surgery Article Highlights Weight Loss Realities, Notes Beverly Hills Physicians

The L.A.-based medical group notes that a healthy diet and exercise regimen may help some individuals lose a modest amount of weight, but for individuals with severe obesity, only bariatric procedures are effective. Los Angeles, CA (PRWEB) May 27, 2016 More than a third of American adults are considered obese, says the National Institutes of Health, so it is not surprising that bariatric surgery ...

Busy Week For FDA Drug Decisions Ends With Two Ayes (& Maybe One More)

The new FDA commissioner Robert Califf told a conference audience this week that he expected “a flood” of new treatments in the near future. Perhaps he meant the following few days. His agency has approved two drugs in the past 36 hours, and another decision is due by Sunday. The FDA just announced that a […]

FDA Grants Accelerated Approval to Ocaliva™ (Obeticholic Acid) for the Treatment of Patients with PBC

First new medicine for PBC in nearly 20 years Investor conference call Tuesday, May 31 at 8:30 a.m. ET NEW YORK, May 27, 2016 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat non-viral, progressive liver diseases, today announced that the U.S. Food and Drug Administ...

Extendicare Announces Voting Results From the 2016 Annual and Special Meeting of Shareholders

MARKHAM, ON--(Marketwired - May 27, 2016) -Extendicare Inc. ("Extendicare" or the "Company") (TSX: EXE) today announced the results of matters voted on Read more...

REFILE-UPDATE 3-Medical experts want Rio Olympics delayed or moved due to Zika

LONDON/WASHINGTON, May 27 (Reuters) - More than 100 medical experts, academia and scientists on Friday have called for the Rio Olympic Games to be postponed or moved because of fears that the event could speed up the spread of the Zika virus around t...

Biogen and AbbVie Receive FDA Approval of Once-Monthly ZINBRYTA™ (daclizumab) for Multiple Sclerosis

CAMBRIDGE, Mass. and NORTH CHICAGO, Ill., May 27, 2016 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) approved ZINBRYTA™ (daclizumab), a new once-monthly, self-administered, subcutaneous treatment for relapsing forms of multiple sclerosis (RMS), Biogen (NASDAQ: BIIB) and AbbVie (NYSE: ABBV) announced today. Because of its safety profile, the use of ZINBRYTA should gene...

Fire Alarm Inspection Can Make the Difference Between Inconvenience and Catastrophe

VANCOUVER, BC--(Marketwired - May 27, 2016) -Community Fire Inspections, a Vancouver-based company that specializes in fire safety and prevention, has an important safety Read more...

Team Support for Solo Ocean Row #ConfrontCancerOceanRow

CALGARY, AB--(Marketwired - May 27, 2016) -Laval St. Germain is about to embark on a journey that will not only test his physical Read more...

Bavarian Nordic - Transactions in Connection with Share Buy-Back Program and Termination of Share Buy-Back Program

COPENHAGEN, Denmark, May 27, 2016 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announces that the share buy-back program, which was announced and initiated on May 26, 2016 (see company announcement no. 18 / 2016), has now been terminated, as the intended number of shares under the program has been repurchased. The program was executed in accordance with the provisions of European C...

Braeburn/Titan Nab Powerful Ally To Push Opioid Dependence Implant

With the FDA's approval in hand, the big question now is whether payers will pay for Braeburn Pharmaceuticals' and Titan...   

Biogen's Monthly MS Injection Wins FDA Approval

(MedPage Today) -- Zinbryta (daclizumab) approved for relapsing MS

Washington state told to lift restrictions on hepatitis C medicines

The ruling came in response to a lawsuit filed by state residents who claim the drugs are “medically necessary,” and that the decision by the Washington State Health Care Authority to provide coverage to only the sickest patients had caused them harm

Brain Scans Probe the Limits of Consciousness

New research from scientists at the University of Copenhagen and Yale University may offer a simple, yet powerful way to pull back the curtain on the true status of patients in a coma. Using a type of Positron Emission Tomography (PET) scanning, the researchers say they were able to predict with 94 percent accuracy whether a coma patient would wake up. Typically, determining who will emerge from ...

Study: How to boost store conversion and traffic

Dan BerthiaumeRetailers are always asking how they can increase the numbers of shoppers who visit and buy goods at their stores. read more

Entire state gets one naloxone prescription

There are many steps that need to be taken to end an epidemic—including policy, medication, coverage and treatment expansion—and require physicians to take the lead in fighting for their patients. Leaders in Pennsylvania are on a mission to provide that help to both the people who are suffering in the opioid epidemics and the physicians who treat them. A standing order for naloxone Throu...

Medical experts want Rio Olympics delayed or moved due to Zika

LONDON/WASHINGTON (Reuters) - More than 100 medical experts, academia and scientists on Friday have called for the Rio Olympic Games to be postponed or moved because of fears that the event could speed up the spread of the Zika virus around the world...

UPDATE 3-Medical experts want Rio Olympics delayed or moved due to Zika

LONDON/WASHINGTON, May 27 (Reuters) - More than 100 medical experts, academia and scientists on Friday have called for the Rio Olympic Games to be postponed or moved because of fears that the event could speed up the spread of the Zika virus around t...

What it’s like to be in endocrine surgery: Shadowing Dr. Krishnamurthy

As a medical student, do you ever wonder what it’s like to be an endocrine surgeon? Here’s your chance to find out. Meet Vikram D. Krishnamurthy, MD, an endocrine surgeon and featured physician in AMA Wire’s® “Shadow Me” Specialty Series, which offers advice directly from physicians about life in their specialties. Read his insights to help determine whether a career in end

Sweet Earth Natural Foods Issues Voluntary Recall of Mispackaged Big Sur Burritos That Contain the Santa Cruz Burrito: Potential Allergy Concern for Those with Milk Allergy

Sweet Earth Natural Foods is voluntarily recalling its Big Sur Burrito, 7 oz, due to a packaging error. As a result, a small number of these products contain an undeclared milk allergen.

What it’s like to be in obesity medicine: Shadowing Dr. Lazarus

As a medical student, do you ever wonder what it’s like to be an obesity specialist? Here’s your chance to find out. Meet Ethan Lazarus, MD, an obesity specialist and featured physician in AMA Wire’s® “Shadow Me” Specialty Series, which offers advice directly from physicians about life in their specialties. Dr. Lazarus is the secretary treasurer of the Obesity Medicine Association (...

PharmaCan Announces Tranche of Private Placement

TORONTO, ON--(Marketwired - May 27, 2016) -  NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH UNITED STATES NEWSWIRE SERVICES PharmaCan Capital Corp. Read more...

Invokana superior to glimepiride for glycemic control, weight loss, BP

ORLANDO, Fla. — Over 52 weeks, glycemic control was improved and body weight and blood pressure were reduced with Invokana as add-on therapy to metformin in patients with type 2 diabetes, according to a presentation here. In the randomized, double blind study, Katherine Merton, PhD, of Janssen Scientific Affairs, and colleagues evaluated data from 1,450 adults (mean age, 56.2 years) with type 2 ...

New incentives needed to develop antibiotics to fight superbugs

NEW YORK, May 27 (Reuters) - Drugmakers are renewing efforts to develop medicines to fight emerging antibiotic-resistant bacteria, but creating new classes of drugs on the scale needed is unlikely to happen without new financial incentives to make t...


Quick Search
Advertisement
 

BioPortfolio's biotechnology, pharmaceutical, healthcare and medical device information service collates press releases, news articles and blogs from over 275 sources.